Microarray analysis revealed downregulation of regucalcin expression levels in pancreatic tissue from 36 PDA patients as compared to tissue from 36 normal pancreases, as determined through the utilization of the GEO database (GSE15471) [35]. This evidence concerns the gene RGN and Patent ductus arteriosus.